To decipher the impact of ARID1B cellular protein abundance in tumor malignancy, we examined the expression of ARID1B in a panel of breast cancer cell lines, including mammary gland epithelial, luminal, HER2+ and TNBC. The gene discussed is ERBB2; the disease is neoplasm.